Inventor

LEARMONTH DAVID ALEXANDER

PT42 patents

⚠️ This page may combine multiple inventors who share the name “LEARMONTH DAVID ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEARMONTH DAVID ALEXANDER

LEARMONTH DAVID ALEXANDER

Nitrocatechol derivatives as COMT inhibitors

Nitrocatechol derivatives as COMT inhibitors

Asymmetric catalytic reduction of oxcarbazepine

Dosage regimen for COMT inhibitors

Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol

Pharmaceutical compounds

Catalytic hydrogenation of ene-carbamates

Process for the synthesis of substituted urea compounds

PORTELA & CA SA

Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them

Method for preparation of (s)-(+)-and(r)-(-)10,11-dihydro-10-hydrodoxy-5h-dibenz/b,f/azephine-5-carboxamide

Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b, f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5h-dibenz/b, f/azepine-5-carboxamide

Method for racemization of (S)-(+)- and (R)-(−)-10,11-dihydro-10-hydroxy-5h-dibenz[B,F]azepine-5-carboxamide and optically enriched mixtures thereof

Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation

Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation

Method for preparation of (S)-(+)- and (R)-(−)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide

Derivatives of 10, 11-Dihydro-10-OXO-5H-Dibenz/B,F/Azepine-5-carboxamide

BIAL PORTELA & CA SA

Intermediate for preparing a catechol-O-methyltransferase inhibitor

Method for preparation of 10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide

Administration regime for nitrocatechols

Process for preparing 1,3-dihydroimidazole-2-thione derivatives

Crystalline forms and processes for their preparation

Preparation of eslicarbazepine and related compounds by asymmetric hydrogenation

BIAL—PORTELA & CA S A

Nitrocatechol derivatives as COMT inhibitors

Administration regime for nitrocatechols

Nitrocatechol derivatives as COMT inhibitors

Dosage regimen for COMT inhibitors

BELIAEV ALEXANDER

Process for preparing 1, 3-Dihydroimidazole-2-Thione Derivatives

Process for preparing synthetic intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase involving catalytic asymmetric hydrogenation

Process for preparing intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase involving catalytic asymmetric hydrogenation

BIAL—PORTELA & C A S A

Asymmetric catalytic reduction of oxcarbazepine

Asymmetric catalytic reduction of oxcarbazepine

BIAL-PORTELA & CA S A

Pharmaceutical compounds

1,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase

SOARES DA SILVA PATRICIO MANUEL VIEIRA ARAUJO

1,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase

Process for the preparation of (R)-5-(2-aminoethyl)-1-(6,8-difluorochroman-3-YL)-1,3-dihydroimidazole-2-thione

STEMMATTERS BIOTECNOLOGIA E MEDICINA REGENERATIVA S A

Gellan gum-based hydrogels, methods and uses thereof

Gellan gum hydrogels, preparation, methods and uses thereof

BIAL—PORTELA & Cª S A

Chemical compound useful as intermediate for preparing a catechol-O-methyltransferase inhibitor

BIAL PORTELA CA & S A

Method for chiral inversion of (S)-(+)-and (R)-(−)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof

BIAL—PORTELA & CA S A (“PORTELA”)

Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nitrobenzene-1,2-diol

PORTELA C A S A

Method for the nitration of phenolic compounds

KISS LASZLO ERNO

Pharmaceutical compounds